All Posts

Digital-Therapeutics-for-depression
Evaluating the Role of Digital Therapeutics as an Alternative to Conventional Therapies for Depression

Depression is a mental condition characterized by prolonged series of poor moods, loss of interest and enjoyment in ordinary activities, and low energy, all of which contribute to varying degrees of social and vocational dysfunction. Depression is a chronic condition that affects a person's ability to work, quality...

Find More

medtech-news-updates-for-iotamotion-recor-natera-boston-scientific
Amber Implants VCFix spinal system; iotaMotion’s iotaSOFT Insertion System; Boston Scientific acquires Baylis; ReCor’s Paradise Ultrasound Renal Denervation; Boston Scientific’s Ranger Drug-Coated Balloon; Natera’s Prospera

Amber Implants VCFix® spinal system obtains US FDA Breakthrough designation  On October 05, 2021, the US Food and Drug Administration (FDA) granted the Breakthrough Device Designation to VCFix® spinal system, a next-generation spinal implant for spinal injuries developed by Amber Implants, a Netherlands-bas...

Find More

global-nutraceuticals-market-cagr-trends-growth-size-share-products-benefits-drawbacks-side-effects
Analyzing the Key Opportunities & Challenges in the Nutraceuticals Market

Nutraceuticals often referred to as phytochemicals or functional food, are a group of products used both as nutrition for general well-being or as a medicine to control symptoms. These products are helpful in maintaining body growth, improving health, delaying the aging process, physiological balance,  increas...

Find More

pharma-biotech-news-updates-for-pfizer-kytopen-eli-lilly-vensana-reify-health
Pfizer tightens DMD trial criteria over safety concerns; Kytopen raises $30M; Eli Lilly taps Reify’s Care Access; Vensana Capital raises $325M

Pfizer tightens DMD patient criteria after serious adverse events in phase 3 gene therapy trial Pfizer is tightening up the criteria for Duchenne muscular dystrophy patients to partake in phase 3 clinical trials of its experimental gene therapy after three severe events were cropping up in ongoing studies. Th...

Find More

myocardial-infarction-market-treatment-growth-size-therapies-forecast-key-companies
Increasing Incidence, Influx of Companies add to the Market Revenue in the Myocardial Infarction Market Space

Myocardial infarction is an irreversible death of heart muscles. It is pathologically referred to as myocardial cell death due to a prolonged lack of oxygen supply (ischemia). The condition is accompanied by chest pain that may appear as a sensation of tightness or pressure initially attributable to diminished cell...

Find More

myasthenia-gravis-treatment-market-growth-size-therapies-forecast-and-key-companies
Exploring the Market Potential of the Upcoming Therapies for the Myasthenia Gravis

Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It occurs when the communication between nerve cells and muscles is disrupted. This impairment prevents critical muscle contractions from occurring, resulting in muscle weakness. This disease is associated with antibodies directed a...

Find More

medtech-happenings-for-neurolief-paige-bionaut-retina-medtronic
RETINA-AI Health declares positive results; Medtronic’s Hugo robotic-assisted surgery system; Boston Scientific acquires Devoro Medical; Paige obtains first-ever FDA approval

RETINA-AI Health, Inc. declares positive pivotal study results for the RETINA-AI Galaxy™ autonomous Diabetic Retinopathy screening device On September 20, 2021, RETINA-AI Health, Inc. announced optimistic results from the pivotal study of the RETINA-AI Galaxy™, a multi-device compatible autonomous ...

Find More

Probiotics Market
Analyzing the Emerging Demand for the Probiotics

Probiotics are a type of beneficial or live bacteria that provides various valuable benefits such as boosting the immune system and maintaining digestive health. Due to their beneficial properties, the demand is growing at a significant rate. Probiotics are available as dietary supplements. In the food supplemen...

Find More

pharma-biotech-news-updates-for-innovent-biohaven-delix-intracellular-therapies
UNION Therapeutics-Innovent’s collaboration; Delix Therapeutics bags $ 70 M; Biohaven’s Verdiperstat clinical trial result; Intra-Cellular’s CAPLYTA Phase III study

Innovent, UNION Therapeutics Set to Advance Dermatology Market in China  Innovent Biologics and UNION therapeutics have announced a strategic and licensing collaboration to develop and commercialize Orismilast, a next-generation PDE4 inhibitor for inflammatory dermatology conditions in China. Orismilast ...

Find More

west-syndrome-market-epidemiology-therapies-treatment-therapeutics-cagr-trends-size-share-growth
Scrutinizing the West Syndrome Market Space from Growth Perspectives

West syndrome is a rare form of neurological disorder, an age-related specific Epileptic Encephalopathy that displays an umbrella of symptoms such as seizures known as epileptic (infantile) spasms, gross EEG abnormalities of hypsarrhythmia and intellectual disability.  There are many different causes of epi...

Find More